Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ANDRX (ADRX) -- Ignore unavailable to you. Want to Upgrade?

To: JonnyCmLately who wrote (44)	3/21/1998 1:40:00 PM
From: PAUL ROBERT ST. ONGE	Read Replies (1) \| Respond to of 127

How would you feel if your company was in the same situation? You would make a strong statement period, and I hardly call Andrx's statement yelling louder or peculiar. I suppose they just should have just ignored it, or should have made no public statement what so ever. Frivilous lawsuits are filed daily, for everything and you should know that. If Andrx's product was complete, and patented before Cymedix, than Cymedix case is lost, which appears to be the case. I agree the door was left open, as I believe their case does not have enough merit to win, and certainly not for a fraction of that amount. You have your opinion, and I have mine. I will gladly place my dollars on the table, and I am sure you will stack your quarters.